Midgard Science

Philogen

Sovicille, Italy philogen.com From their website, Nov 2026

  • GMP
  • ISO 9001

Work here? Claim this listing

About

Philogen is a Swiss-Italian biotechnology company founded in 1996 that discovers, manufactures, and develops targeted drugs for cancer and other serious conditions. It operates from sites in Italy and Switzerland and runs work from discovery through clinical development.

Services

  • Target discovery

    Identifies accessible disease targets and discovers antibodies and small organic ligands.

  • Ligand screening through discovery collaborations

    Offers flexible collaboration structures for screening binders against one or multiple targets using proprietary discovery platforms.

  • DNA-encoded library discovery

    Uses DNA-encoded chemical libraries for fast and cost-effective drug discovery.

  • Antibody discovery

    Uses antibody phage libraries to isolate fully human monoclonal antibodies against antigens of interest.

  • Cyclic peptide discovery

    Uses proprietary phage libraries of short cyclic peptides for screening and binder isolation.

  • Prototype development

    Couples targeting ligands with bioactive payloads to generate targeted drug candidates.

  • Preclinical evaluation

    Tests targeted drugs in preclinical models.

    ADME, DMPK & toxicology

  • Cell line development

    Provides customized activities for cell line development in collaboration settings.

    Cell line development

10 more services
  • GMP manufacturing
  • Manufacturing collaborations
  • Clinical trial management
  • Bioanalytics
  • Preclinical development
  • Clinical development
  • Discovery collaborations
  • DNA-encoded library screening
  • R&D discovery
  • Clinical trials

Capabilities

Processes
  • Small molecule
  • Antibody
  • Peptide
  • Cell therapy
  • Recombinant protein
  • Bioanalysis
Capacity
  • More than one billion compounds
  • More than 100 billion members
  • Two GMP manufacturing facilities near Siena
  • Up to Phase III clinical trials
  • 21 clinical trials
  • More than one billion compounds in DNA-encoded chemical libraries
  • More than 100 billion members in antibody phage libraries
  • More than 100 billion members in short cyclic peptide phage libraries

Equipment

  • DNA-encoded chemical libraries
  • Antibody phage libraries

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

  • GLPSelf-reported

  • ISO 9001:2015Self-reported

Industries served

  • Biotech
  • Pharmaceuticals
  • Oncology

Details

Type
CRDMO
Founded
1996
Based in
Sovicille, Italy
Sites
  • Siena, Italy
  • Monteriggioni (SI), Italy
  • Milano, Italy
  • Otelfingen, Switzerland
  • Monteriggioni, Italy
  • Zürich, Switzerland
Phone
(+39) 0577.1781.6

Similar labs